Volume of Distribution
Also known as: Vd · apparent volume of distribution
Volume of distribution (Vd) is the volume a drug would have to fill, at its plasma concentration, to account for all the drug in your body.
Vd is a proportionality constant, not a real space: the total amount of drug in the body divided by its plasma concentration. If most of the drug stays in the blood, plasma concentration is high and Vd is small. If the drug binds in tissues, plasma concentration is low relative to the amount in the body and Vd is large, sometimes larger than the body itself. Binding to plasma proteins pulls Vd down; binding in tissues pushes it up.
Peptides typically have small volumes of distribution, frequently no larger than the volume of fluid outside the body's cells. Long-acting GLP-1 drugs are a clear case: semaglutide is more than 99% bound to albumin, and its label reports an apparent volume of distribution of about 12.5 L after SubQ dosing. 'Apparent' means the value was not corrected for bioavailability (it is V/F), which is how SubQ labels usually report it.
Why it matters
Vd links a blood level to the amount of drug in your body, and together with clearance it sets half-life: t½ = 0.693 × Vd / CL. At the same clearance, a larger Vd means a longer half-life. Vd is also the number used to calculate a loading dose, the amount needed to reach a target concentration right away rather than after several half-lives.
A large Vd does not mean a drug concentrates in the tissue you care about. It is a whole-body figure that cannot tell you whether a peptide reaches a tendon, the gut or the brain. Claims that a research peptide 'goes where it's needed' because of its distribution volume are not something Vd can show.
How to calculate it
- Take the amount that reached circulation (dose × F) and a plasma concentration measured after distribution has settled.
- Convert units so they match: 1 ng/mL equals 1 mcg/L.
- Divide the amount by the concentration.
- To work backward to the amount needed for a target level, multiply Vd by that concentration.
Vd = amount in body / plasma concentration; amount needed = Vd × target concentration
Hypothetical: 1,000 mcg reaches circulation and the plasma concentration after distribution is 80 ng/mL, which is 80 mcg/L. Vd = 1,000 / 80 = 12.5 L. Reversing it, reaching 40 ng/mL (40 mcg/L) in that same volume would take 12.5 L × 40 mcg/L = 500 mcg in the body. These are illustration numbers, not a dose for any compound.
Common mistakes
- Reading Vd as a physical place in the body.
- Assuming a large Vd means the drug accumulates at an injury or target site.
- Comparing an apparent Vd from a SubQ label (not corrected for bioavailability) directly with a Vd from an intravenous study.
- Forgetting that 1 ng/mL equals 1 mcg/L when doing the division.
- Using a Vd from an animal study for human calculations.
Sources
- ReviewVolumes of distribution. J Vet Pharmacol Ther, 2004. PMID 15601439.
- ReviewPharmacokinetics and pharmacokinetic-pharmacodynamic correlations of therapeutic peptides. Clin Pharmacokinet, 2013. PMID 23719681.
- Prescribing informationOZEMPIC (semaglutide) injection, for subcutaneous use: Prescribing Information. Novo Nordisk (FDA-approved labeling), 2026.
Page updated . How we grade evidence: methodology.
Related Terms
Clearance Rate
Clearance (CL) is the volume of plasma your body fully clears of a drug per unit of time, usually given in liters per hour.
Tissue Residency
Tissue residency is an informal term for how long a drug stays in a tissue, or bound to its target, after blood levels fall. It is not a standard PK parameter.
Half-Life
Half-life (t½) is the time it takes for the concentration of a drug in your blood plasma to fall by half.
Look up any peptide term inside DoseCraft Pro
The glossary is just the start. Inside DoseCraft you get 90+ compound deep-dives, a PK-aware protocol engine, interaction checker, and vendor trust scores — every term surfaced in protocol-design context, not a separate page.
Start Free Trial